跳至主要内容
临床试验/NCT05186480
NCT05186480Unknown不适用

Evaluation of the Effect of Immune Modulating Enteral Nutrition Formula Versus Regular Enteral Nutrition on the Outcome of Critically Ill Sepsis Patients. A Pilot Study

NewGiza University1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2021年10月3日最近更新:
适应症

试验速览

阶段
不适用
入组人数
40
试验地点
1
主要终点
oxygen supply

研究概览

简要总结

The aim is to compare the efficacy and tolerability of an immune modulating enteral nutrition formula versus the regular formula on the outcomes of critically ill septic patients by assessment of clinical outcomes, immune profile, tolerability and enteral nutrition intolerance and laboratory markers

详细描述

Nutritional formulas are considered important sources of the dietary components that the body requires. They contain the sources of fats, proteins and carbohydrates and compensate any vitamin and mineral deficiency.

There is a special type of formulas called the "immune-enhancing formulas", they supplement the body not only with the energy sources but also, they boost the body's immune system as they contain multiple types of amino and fatty acids.

There is an ongoing debate around the efficacy of the immune-enhancing formulas, some studies show that they make a significant difference in enhancing the clinical outcomes compared to traditional formulas while other studies showed no significant difference between the traditional formulas and immune-enhancing formula.

The immune-enhancing nutritional formula is used in enteral and oral feeding for critically ill patients. It's mainly indicated in cases of malnutrition, post surgeries and traumas and immunocompromised patients.

Its composition:

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Single (Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosed with sepsis according to guideline criteria AND
  • Age ≥18 years

排除标准

  • Gastrointestinal tract complications or intestinal failure or any contraindications to receive enteral nutrition
  • Hemodynamic instability on admission

结局指标

主要结局

oxygen supply

时间窗: 28 days

arterial blood gases

inflammatory markers

时间窗: 28 days

C-Reactive protein

severity of disease classification

时间窗: 28 days

acute physiology and chronic health evaluation score

immune profile

时间窗: 28 days

C-Reactive protein

critical care need

时间窗: 28 days

days on oxygen supply

fluid status

时间窗: 28 days

albumin

Intensive Care Unit mortality

时间窗: 28 days

The Sequential Organ Failure Assessment score

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Rana Muhammed

Principle Investigator

NewGiza University

研究点 (1)

Loading locations...

相似试验

Evaluation of the Effect of Immune Modulating... | 临床试验